ICU MEDICAL INC/DE (ICUI) FY2026 YTD Q2 P&L / Income Statement

ICU MEDICAL INC/DE (ICUI) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

TOTAL REVENUES

1,081,908,000 US dollars

Cost of goods sold

640,629,000 US dollars

Gross Profit

441,279,000 US dollars

TOTAL OPERATING EXPENSES

388,573,000 US dollars

INCOME (LOSS) FROM OPERATIONS

52,706,000 US dollars

Other income (expense), net (calculated)

negative 33,537,000 US dollars

Income (loss0 before income taxes and equity in earnings of unconsolidated affiliates

19,169,000 US dollars

PROVISION FOR INCOME TAXES

negative 27,644,000 US dollars

NET INCOME (LOSS)

49,219,000 US dollars

Infusion Consumables

567,551,000 US dollars

Infusion Systems

368,602,000 US dollars

Vital Care

145,755,000 US dollars

Selling, general and administrative

306,488,000 US dollars

Research and development

43,982,000 US dollars

Restructuring, strategic transaction and integration

38,103,000 US dollars

Equity in Earnings of Unconsolidated Affiliates

2,406,000 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.